南微医学(688029)
 
 
  日线
顶尖财经网欢迎您!
  K线
 
 最新动态
  投资评级

  盈利预测
据南微医学一季报分析:

  盈利能力维持稳定,主营获利能力保持稳定

  成长能力有所削弱,公司规模由扩张变为收缩

  偿债能力维持稳定,短期偿债能力很强

  运营能力维持稳定,流动资产的周转速度需要加快

  现金流能力有所加强,公司资金利用效率获小幅提升

  财务数据
2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
每股收益(元)1.630.783.052.721.940.862.952.41
每股净资产(元)22.2922.5821.9921.6821.4521.2620.3719.86
每股资本公积金(元)10.2410.2410.2210.2210.2110.2110.2010.20
每股未分配利润(元)11.0211.1810.4010.089.809.728.868.32
每股经营性现金流(元)1.330.573.662.541.610.383.262.03
净资产收益率(%)7.193.5014.2512.759.114.1214.8512.21
营业总收入(元)17.28亿8.54亿31.84亿23.81亿15.65亿6.99亿27.55亿20.12亿
营业总收入同比增长(%)10.3922.1115.5518.2917.3612.7514.2615.31
归属净利润(元)3.03亿1.46亿5.70亿5.09亿3.63亿1.61亿5.53亿4.51亿
归属净利润同比增长(%)-16.50-8.993.0912.9017.0412.1813.8516.70
扣非净利润(元)2.97亿1.43亿5.52亿5.08亿3.64亿1.61亿5.44亿4.46亿
扣非净利润同比增长(%)-18.33-11.181.4413.8918.9014.2017.4818.11
毛利率(%)64.8564.0164.0964.5564.8965.6967.6567.64
净利率(%)17.8517.4218.3022.2724.2623.9120.6223.06
资产负债率(%)19.1116.5820.5318.2717.3415.9818.4216.74
存货周转率(次)0.970.481.971.450.940.421.681.23
  主营收入+营业利润
 
  净利润+每股收益
  股东权益+未分配利润
 
  总资产+负债
  投资要点
利润表
报告期2026-06-302026-03-312025-12-312025-09-30
营业总收入1,727,947,419.23853,734,897.793,183,783,900.372,380,540,402.29
营业总成本1,348,475,630.82670,832,383.742,480,891,3061,755,895,594.02
其他经营收益
营业利润377,686,481.32181,630,262.24691,689,338.27626,310,214.27
利润总额377,824,389.21182,004,326.77691,153,946.26626,627,247.01
净利润308,468,034.18148,722,793.11582,557,650.02530,090,341.12
每股收益
其他综合收益-71,631,554.82-41,562,531.5850,506,340.7129,811,229.06
综合收益总额236,836,479.36107,160,261.53633,063,990.73559,901,570.18
资产负债表
报告期2026-06-302026-03-312025-12-312025-09-30
流动资产:
流动资产合计3,337,498,558.793,304,918,483.943,642,199,115.163,475,983,589.07
非流动资产:
非流动资产合计2,100,962,257.92,032,413,976.821,821,593,506.61,716,428,619.23
资产总计5,438,460,816.695,337,332,460.765,463,792,621.765,192,412,208.3
流动负债:
流动负债合计936,038,827.77773,754,431.711,003,875,018.34863,789,230.26
非流动负债:
非流动负债合计103,109,403.44111,026,962.87117,744,833.9384,849,502.08
负债合计1,039,148,231.21884,781,394.581,121,619,852.27948,638,732.34
所有者权益(或股东权益):
归属于母公司股东权益合计4,187,069,191.714,242,095,493.254,130,443,252.664,071,956,863.63
股东权益合计4,399,312,585.484,452,551,066.184,342,172,769.494,243,773,475.96
负债和股东权益合计5,438,460,816.695,337,332,460.765,463,792,621.765,192,412,208.3
现金流量表
报告期2026-06-302026-03-312025-12-312025-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,716,385,930.12861,399,794.713,422,947,030.982,566,433,223.22
经营活动现金流出小计1,466,423,677.87754,997,016.012,735,001,277.352,088,904,722.76
经营活动产生的现金流量净额249,962,252.25106,402,778.7687,945,753.63477,528,500.46
投资活动产生的现金流量:
投资活动现金流入小计5,198,936,641.872,482,436,060.161,626,230,255.44940,416,025.24
投资活动现金流出小计5,400,547,482.622,863,735,699.492,551,240,606.251,042,558,227.7
投资活动产生的现金流量净额-201,610,840.75-381,299,639.33-925,010,350.81-102,142,202.46
筹资活动产生的现金流量:
筹资活动现金流入小计205,027,781.85,027,781.8198,000,002.8198,000,002.8
筹资活动现金流出小计387,438,803.91194,851,199.22401,828,217.96387,997,687.53
筹资活动产生的现金流量净额-182,411,022.11-189,823,417.42-203,828,215.16-189,997,684.73
汇率变动对现金及现金等价物的影响-74,043,735.23-41,618,903.547,352,730.8930,364,694.28
现金及现金等价物净增加额-208,103,345.84-506,339,181.59-433,540,081.45215,753,307.55
期末现金及现金等价物余额1,228,572,710.91930,336,875.161,436,676,056.752,085,969,445.75
补充资料:
现金及现金等价物的净增加额-208,103,345.84--433,540,081.45-
  十大流通股东
  主力控盘
  公司简介



以上信息为合作方、加盟公司及会员收集,本站不拥有版权,版权归原作者所有,所载文章、数据仅供参考,据此操作,风险自负。

中 华 顶 尖 财 经 -- 中 华 顶 尖 网 络 信 息 服 务 中 心